Search clinical trials for: Zavegepant

Total 14 results

Pfizer

Completed

Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

Acute Migraine

United States
Pfizer

Completed

A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants

Healthy

China
Pfizer

Terminated

Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

Asthma

Canada
Pfizer

Completed

Randomized Trial in Adult Participants With Acute Migraines

Migraine

United States
Pfizer

Recruiting

A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

Migraine

Taiwan, China, Korea, Republic of
Pfizer

Terminated

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Migraine

United States
Pfizer

Terminated

Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen

COVID-19 Infection

United States
Mayo Clinic

Not yet recruiting

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

Migraine

United States
Pfizer

Not yet recruiting

A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

Migraine
Pfizer

Completed

Acute Treatment Trial in Adult Subjects With Migraines

Migraine

United States
Pfizer

Completed

A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling

Healthy

United States
Pfizer

Not yet recruiting

A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women

Healthy

United States
Pfizer

Completed

A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers

Biological Availability

United States
Kite, A Gilead Company

Recruiting

Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (JKART-1)

Relapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Japan

3

Subscribe